---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-028783"
form_type: "8-K"
ticker: "SUPN"
cik: "0001356576"
company_name: "SUPERNUS PHARMACEUTICALS, INC."
filed_at: "2024-02-28T23:59:59+00:00"
generated_at: "2026-06-05T08:27:34.026912+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Supernus Pharmaceuticals boosts CEO and executive compensation, grants equity

## Summary
- CEO Jack Khattar salary raised to $1,001,500; 2023 bonus of $830,588; options for 322,000 shares.
- CFO Timothy Dec salary raised to $485,500; 2023 bonus of $210,558; options for 50,000 shares plus RSUs/PSUs.
- Four other officers (Bhatt, Rubin, Martin, Mottola) received salary increases and equity awards.

## SEC filing metadata
- accession: 0001104659-24-028783
- form_type: 8-K
- ticker: SUPN
- cik: 0001356576
- company_name: SUPERNUS PHARMACEUTICALS, INC.
- filed_at: 2024-02-28T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1356576/000110465924028783/0001104659-24-028783-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1356576/000110465924028783/tm247469d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-028783
- JSON: https://secwatch.observer/filing/0001104659-24-028783.json
- Plain text: https://secwatch.observer/filing/0001104659-24-028783.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.